BlackRock Institutional Trust’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-283,394
Closed -$28.4M 4045
2015
Q1
$28.4M Buy
283,394
+144,914
+105% +$9.65M ﹤0.01% 1711
2014
Q4
$7.27M Buy
138,480
+23,856
+21% +$701K ﹤0.01% 2546
2014
Q3
$2.94M Buy
114,624
+9,142
+9% +$194K ﹤0.01% 2900
2014
Q2
$2.35M Buy
105,482
+11,062
+12% +$242K ﹤0.01% 3120
2014
Q1
$2.9M Buy
+94,420
New +$2.54M ﹤0.01% 3010

BlackRock Institutional Trust's ASPX Position: Q2 2015 in Review

BlackRock Institutional Trust sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 283,394 shares — an estimated $28.4M sold.

BlackRock Institutional Trust first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $28.4M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BlackRock Institutional Trust reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 283,394 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $28.4M.
  • BlackRock Institutional Trust first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • BlackRock Institutional Trust's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $28.4M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Institutional Trust's 13F filing for Q2 2015, filed 7 Aug 2015.